Sino Biopharmaceutical Limited

Sino Biopharmaceutical Ltd Units Thailand Depositery Receipts Repr 0.01 Sh's next confirmed earnings release is scheduled for April 1, 2027.

As of December 31, 2021, Sino Biopharmaceutical Ltd Units Thailand Depositery Receipts Repr 0.01 Sh has 94.36B shares outstanding.

As of December 31, 2021, Sino Biopharmaceutical Ltd Units Thailand Depositery Receipts Repr 0.01 Sh maintains a current ratio of 1.53, meaning it holds 1.5x the short-term assets needed to cover near-term liabilities.

These figures cover the twelve months ended December 31, 2021.

Over the twelve months ended December 31, 2021, Sino Biopharmaceutical Ltd Units Thailand Depositery Receipts Repr 0.01 Sh recorded 6.44B in income tax expense.

These figures are as of the close on October 22, 2026.

As of December 31, 2021, Sino Biopharmaceutical Ltd Units Thailand Depositery Receipts Repr 0.01 Sh holds 82.55B in cash and equivalents against 63.33B in total debt, resulting in a net debt position of 6.09B. Total book value stands at 158.32B, with working capital of 42.64B providing operational flexibility.